Medically reviewed by Mary Choy, PharmD Key Takeaways Cymbalta and Lexapro are both used to treat depression and anxiety disorders, but they are different drug classes.Cymbalta is also approved to ...

Patients on Cymbalta experienced a statistically longer time to relapse of depression than did patients on placebo. Relapse was defined as an increase of two or more points on the Clinical Global ...

INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta(R) (duloxetine HCl) for the maintenance treatment of ...

INDIANAPOLIS Eli Lilly and Co.’s anti-depression drug, Cymbalta, has received government approval for long-term use, the company said Friday. The Indianapolis-based drugmaker said that the Food and ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...

INDIANAPOLIS, July 6, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity ...

surged Wednesday after the Indianapolis-based drug company said the federal government had given conditional approval for its antidepressant Cymbalta. The conditions outlined by the Food and Drug ...

It could be another Prozac moment. Eli Lilly and Co. is pitching its next star antidepressant drug, Cymbalta, for approval to treat the poorly understood pain of fibromyalgia. Regulators OK’d a drug ...

The Food and Drug Administration approved sale of a new antidepressant for adults on Wednesday. Called Cymbalta, it should be on pharmacy shelves by late month. Maker Eli Lilly & Co. is banking on ...

Over 230,000 bottles of the antidepressant duloxetine (Cymbalta) have been recalled due to the presence of a potential carcinogen. (USA Today) In an exploratory analysis of two phase III trials, ...

ROCKVILLE, Md., July 5-Adults using antidepressants may have an increased risk of suicidal behavior, especially when initiating treatment or when changing doses, said the FDA. In a Public Health ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...